Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Longitudinal Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis

NCT01541618 is registered in ClinicalTrials.gov with MSDx, Inc. as lead sponsor.

NCT NCT01541618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01541618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Longitudinal Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis
Lead sponsor
MSDx, Inc.
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
July 31, 2012
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing remitting multiple sclerosis